Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Galluzzo

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Clinical, Cosmetic and Investigational Dermatology|December 18, 2023
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 StudyFilomena Russo, Marco Galluzzo, Luca Stingeni, et al.
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab TherapyAndrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Journal of Clinical Medicine|February 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology|April 15, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis)Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Dermatology Practical & Conceptual|November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2026
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatologyFranco Scaldaferri, Federica Di Vincenzo, Gennaro Marco Falco, et al.
Clinical and Experimental Dermatology|April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN StudyMarina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areataAlfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Clinical, Cosmetic and Investigational Dermatology|December 18, 2023
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 StudyFilomena Russo, Marco Galluzzo, Luca Stingeni, et al.
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab TherapyAndrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Journal of Clinical Medicine|February 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology|April 15, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis)Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Dermatology Practical & Conceptual|November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2026
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatologyFranco Scaldaferri, Federica Di Vincenzo, Gennaro Marco Falco, et al.
Clinical and Experimental Dermatology|April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN StudyMarina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areataAlfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.
Pageof 12